[{"address1": "18105 SE Mill Plain Boulevard", "city": "Vancouver", "state": "WA", "zip": "98683", "country": "United States", "phone": "360 949 1041", "website": "https://www.absci.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.", "fullTimeEmployees": 156, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean  McClain", "age": 34, "title": "Founder, CEO, President & Director", "yearBorn": 1990, "fiscalYear": 2024, "totalPay": 1070440, "exercisedValue": 0, "unexercisedValue": 1131078}, {"maxAge": 1, "name": "Dr. Zachariah  Jonasson Ph.D.", "age": 51, "title": "Chief Business Officer & CFO", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 813300, "exercisedValue": 0, "unexercisedValue": 250000}, {"maxAge": 1, "name": "Dr. Andreas  Busch Ph.D.", "age": 61, "title": "Chief Innovation Officer & Member of Scientific Advisory Board", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1172058, "exercisedValue": 0, "unexercisedValue": 146781}, {"maxAge": 1, "name": "Mr. Alexander  Khan CPA", "title": "VP of Finance & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shelby  Walker J.D.", "age": 49, "title": "Chief Legal Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karin  Wierinck", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Melissa  Patterson Ph.D.", "title": "Chief of Staff", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Wen  Sha", "title": "Chief of Staff", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christine  Lemke D.V.M., M.B.A., Ph.D.", "title": "Senior Vice President of Portfolio & Growth Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christian  Stegmann M.B.A., Ph.D.", "title": "Senior Vice President of Drug Creation", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.56, "open": 2.57, "dayLow": 2.56, "dayHigh": 2.725, "regularMarketPreviousClose": 2.56, "regularMarketOpen": 2.57, "regularMarketDayLow": 2.56, "regularMarketDayHigh": 2.725, "payoutRatio": 0.0, "beta": 2.037, "forwardPE": -3.7042255, "volume": 3843443, "regularMarketVolume": 3843443, "averageVolume": 4861500, "averageVolume10days": 5524570, "averageDailyVolume10Day": 5524570, "bid": 2.59, "ask": 2.66, "bidSize": 18, "askSize": 3, "marketCap": 393245536, "fiftyTwoWeekLow": 2.01, "fiftyTwoWeekHigh": 6.33, "priceToSalesTrailing12Months": 95.03275, "fiftyDayAverage": 2.8542, "twoHundredDayAverage": 3.16895, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 283198560, "profitMargins": 0.0, "floatShares": 132166058, "sharesOutstanding": 149523008, "sharesShort": 30406020, "sharesShortPriorMonth": 32103327, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.21079999, "heldPercentInsiders": 0.09255, "heldPercentInstitutions": 0.59858, "shortRatio": 4.82, "shortPercentOfFloat": 0.2497, "impliedSharesOutstanding": 149523008, "bookValue": 1.358, "priceToBook": 1.9366716, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -113296000, "trailingEps": -0.95, "forwardEps": -0.71, "enterpriseToRevenue": 68.439, "enterpriseToEbitda": -2.73, "52WeekChange": -0.4142539, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 2.63, "targetHighPrice": 10.0, "targetLowPrice": 5.89, "targetMeanPrice": 8.12714, "targetMedianPrice": 8.0, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 117458000, "totalCashPerShare": 0.786, "ebitda": -103730000, "totalDebt": 7412000, "quickRatio": 3.772, "currentRatio": 4.387, "totalRevenue": 4138000, "debtToEquity": 4.275, "revenuePerShare": 0.034, "returnOnAssets": -0.31260002, "returnOnEquity": -0.57385, "grossProfits": -67646000, "freeCashflow": -33263124, "operatingCashflow": -76408000, "revenueGrowth": -0.533, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -52.939293, "financialCurrency": "USD", "symbol": "ABSI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 2.73438, "regularMarketPrice": 2.63, "corporateActions": [], "postMarketTime": 1755906961, "regularMarketTime": 1755892801, "marketState": "CLOSED", "shortName": "Absci Corporation", "longName": "Absci Corporation", "exchange": "NMS", "messageBoardId": "finmb_266013918", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626960600000, "postMarketChangePercent": 1.9011388, "postMarketPrice": 2.68, "postMarketChange": 0.049999952, "regularMarketChange": 0.0700002, "regularMarketDayRange": "2.56 - 2.725", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4861500, "fiftyTwoWeekLowChange": 0.6200001, "fiftyTwoWeekLowChangePercent": 0.30845776, "fiftyTwoWeekRange": "2.01 - 6.33", "fiftyTwoWeekHighChange": -3.6999998, "fiftyTwoWeekHighChangePercent": -0.58451813, "fiftyTwoWeekChangePercent": -41.42539, "earningsTimestamp": 1755028800, "earningsTimestampStart": 1762891200, "earningsTimestampEnd": 1762891200, "earningsCallTimestampStart": 1755117000, "earningsCallTimestampEnd": 1755117000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.95, "epsForward": -0.71, "epsCurrentYear": -0.79167, "priceEpsCurrentYear": -3.3220913, "fiftyDayAverageChange": -0.22419977, "fiftyDayAverageChangePercent": -0.07855083, "twoHundredDayAverageChange": -0.53894997, "twoHundredDayAverageChangePercent": -0.1700721, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-22", "prevName": "Absci, CORP", "nameChangeDate": "2025-08-22", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Absci", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]